Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director | September 03, 2026 | September 08, 2026 |
| Lifeward Ltd.LFWD · Entity 7620 | Director · Chief Executive Officer | May 21, 2025 | May 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.6103 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.5195 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.1836 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 5.486 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 4.2988 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Lifeward Ltd.
Report date May 21, 2025 · Filed May 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | IndirectESOP | 98,728 |
Reported balance
After 2025-05-21 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-05-21 · Sale · Disposed 1,909 · Balance 98,728 F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person. |
| Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivative | Direct | 2,142 |
Reported balance
Holding disclosure · report date 2025-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,142 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 04, 2017 Filed Oct 6, 2017 21:27 UTC | Lifeward Ltd. RWLK · Entity 7620 | Disposition to issuerOption (Right to buy) · Derivative | 130,000 | Not disclosed Strike: $7.30 | Not disclosed |
DisclosureSEC source: 0001628280-17-009768 · wf-form4_150732526459303.xml · derivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 130,000 shares Expires 2025-12-03 F3 · price: Represents stock options granted under the 2014 Plan on December 3, 2015. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled stock options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant. F3 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on December 3, 2015. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled stock options become vested and exercisable in 12 equal quarterly installments starting on the first anniversary of the date of grant. Read SEC document |
| October 04, 2017 Filed Oct 6, 2017 21:27 UTC | Lifeward Ltd. RWLK · Entity 7620 | Disposition to issuerOption (Right to buy) · Derivative | 62,864 | Not disclosed Strike: $20.77 | Not disclosed |
DisclosureSEC source: 0001628280-17-009768 · wf-form4_150732526459303.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 62,864 shares Expires 2024-12-15 F2 · price: Represents stock options granted under the 2014 Plan on December 15, 2014. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled stock options become vested and exercisable in 48 equal monthly installments starting one month following the date of grant. F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on December 15, 2014. The options were cancelled on October 4, 2017 as part of the equity exchange program and were replaced with RSUs. The cancelled stock options become vested and exercisable in 48 equal monthly installments starting one month following the date of grant. Read SEC document |
| September 15, 2017 Filed Sep 18, 2017 20:13 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 613 | $1.80 | $1,103.40 |
DisclosureSEC source: 0001628280-17-009375 · wf-form4_150576560008222.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 66,280 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Friday, September 15, 2017 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| August 28, 2017 Filed Aug 28, 2017 20:13 UTC | Lifeward Ltd. RWLK · Entity 7620 | SaleOrdinary Shares, par value NIS 0.01 per share | 413 | $1.65 | $681.45 |
DisclosureSEC source: 0001628280-17-008933 · wf-form4_150395122213038.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 66,893 F1 · shares: Represents Ordinary Shares sold in the open market on August 28, 2017, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on August 24, 2017, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 20:37 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 2,030 | $34.23 | $69,486.90 |
DisclosureSEC source: 0001209191-17-049716 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001209191-17-047569 · doc4.xml · derivative · entry 7 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 1,500 shares Expires 2021-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $11.43 | $0.00 |
DisclosureSEC source: 0001209191-17-047569 · doc4.xml · derivative · entry 6 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2020-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $7.87 | $0.00 |
DisclosureSEC source: 0001209191-17-047569 · doc4.xml · derivative · entry 5 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2019-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining two years. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 6,500 | $34.47 | $224,064.10 |
DisclosureSEC source: 0001209191-17-047569 · doc4.xml · nonDerivative · entry 4 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,363 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $34.37 to $34.58. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 1,500 | $14.13 | $21,195.00 |
DisclosureSEC source: 0001209191-17-047569 · doc4.xml · nonDerivative · entry 3 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $11.43 | $28,575.00 |
DisclosureSEC source: 0001209191-17-047569 · doc4.xml · nonDerivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,363 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| August 01, 2017 Filed Aug 4, 2017 00:36 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2,500 | $7.87 | $19,675.00 |
DisclosureSEC source: 0001209191-17-047569 · doc4.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 12:40 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 125,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001628280-17-006795 · wf-form4_149874004579003.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Ordinary Shares, par value NIS 0.01 per share · 125,000 shares Expires 2027-06-27 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on June 27, 2017. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 12:40 UTC | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-006795 · wf-form4_149874004579003.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 67,306 F1 · shares: Represents 20,000 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on June 27, 2017. The RSUs vest in four equal yearly installments following the date of the grant. The RSUs may only be settled in Ordinary Shares. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 17:45 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOption (Right to buy) · Derivative | 125,000 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001628280-17-006814 · wf-form4a_149875831267137.xml · derivative · entry 2 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Ordinary Shares, par value NIS 0.01 per share · 125,000 shares Expires 2027-06-27 F2 · derivative.exercise_date: Represents stock options granted under the 2014 Plan on June 27, 2017. One-fourth of the options become vested and exercisable on the first anniversary of the date of the grant, with the remaining options vesting in twelve equal quarterly installments thereafter. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 17:45 UTC Amendment | Lifeward Ltd. RWLK · Entity 7620 | GrantOrdinary Shares, par value NIS 0.01 per share | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-17-006814 · wf-form4a_149875831267137.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 67,306 F1 · shares: Represents 25,000 Ordinary Shares issuable upon the vesting of restricted stock units ("RSUs") granted under the ReWalk Equity Incentive Plan (the "2014 Plan") on June 27, 2017. The RSUs vest in four equal yearly installments following the date of the grant. The RSUs may only be settled in Ordinary Shares. Read SEC document |
| June 15, 2017 Filed Jun 16, 2017 19:06 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 612 | $1.15 | $703.80 |
DisclosureSEC source: 0001628280-17-006530 · wf-form4_149763999959424.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 42,306 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Thursday, June 15, 2017 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| May 30, 2017 Filed May 30, 2017 20:13 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 1,782 | $1.20 | $2,138.40 |
DisclosureSEC source: 0001628280-17-006020 · wf-form4_149617519157956.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 42,918 F1 · shares: Represents Ordinary Shares sold in the open market on May 30, 2017, in order to satisfy the reporting person's tax withholding obligation in connection with the vesting, on May 24, 2017, of certain restricted stock units ("RSUs") previously granted to the reporting person under the ReWalk 2014 Equity Incentive Plan. One-fourth of these RSUs vested on May 24, 2017, the first anniversary of the date of grant, with the remaining RSUs vesting in twelve equal quarterly installments thereafter. Read SEC document |
| March 15, 2017 Filed Mar 20, 2017 11:35 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 622 | $1.95 | $1,212.90 |
DisclosureSEC source: 0001628280-17-002704 · wf-form4_149000971993122.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 44,700 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Wedensday, March 15, 2017 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 22:02 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 596 | $2.75 | $1,639.00 |
DisclosureSEC source: 0001607962-16-000026 · wf-form4_148192573893065.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 45,322 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Thursday, December 15, 2016 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 10:00 UTC | Lifeward Ltd. RWLK · Entity 7620 | Tax withholdingOrdinary Shares, par value NIS 0.01 per share | 596 | $5.74 | $3,421.04 |
DisclosureSEC source: 0001607962-16-000018 · wf-form4_147402001802531.xml · nonDerivative · entry 1 Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · ESOP Disclosed balance after: 45,918 F1 · shares: Represents Ordinary Shares withheld by ReWalk Robotics Ltd. (the "Company") at the Reporting Person's request, as permitted under the ReWalk 2014 Equity Incentive Plan, to satisfy the Reporting Person's tax withholding obligation in connection with the vesting on Thursday, September 15, 2016 of restricted stock units previously awarded to the Reporting Person. There was no open market sale of Ordinary Shares by the Reporting Person. F2 · price: Closing market price per share of the Company's Ordinary Shares on the transaction date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.